Spyre Therapeutics, Inc.
Institutional holders · 13F as of Dec 31, 2025
| Holder | Value | % of shares |
|---|---|---|
| DRIEHAUS CAPITAL MANAGEMENT LLC | $94.43M | 3.27% |
| TANG CAPITAL MANAGEMENT, LLC | $95.44M | 2.15% |
| Capital International Investors | $114.42M | 3.96% |
| VR Adviser, LLC | $120.74M | 4.18% |
| Remedium Capital Partners, LLC | $129.99M | 1.66% |
| Fairmount Funds Management LLC | $131.63M | 4.56% |
| VANGUARD GROUP INC | $132.19M | 4.58% |
| RTW Investments, LP | $136.67M | 4.73% |
| Perceptive Advisors LLC | $190.83M | 4.29% |
| STATE STREET CORPORATION | $271.44M | 3.47% |
| FMR LLC | $381.29M | 13.20% |
| BlackRock, Inc. | $577.66M | 7.38% |